Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial

BACKGROUND: In the multi-country PROMISE 1077BF trial, the risk of low birth weight (LBW; <2500g) and preterm delivery (PTD; <37 weeks) was higher among women initiating a protease inhibitor (PI)-based antiretroviral treatment (ART) regimen than in those receiving ZDV alone. Among those assign...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Acquir Immune Defic Syndr
Egile Nagusiak: Sebikari, Dorothy, Farhad, Mona, Fenton, Terry, Owor, Maxensia, Stringer, Jeffrey S. A., Qin, Min, Chakhtoura, Nahida, Chi, Benjamin H., Saidi, Friday, Nevrekar, Neetal, Violari, Avy, Chipato, Tsungai, McIntyre, James A., Moodley, Dhayendre, Taha, Taha E., Theron, Gerhard, Fowler, Mary Glenn
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702964/
https://ncbi.nlm.nih.gov/pubmed/31295174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002072
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak